Expression of zinc finger 23 gene in human hepatocellular carcinoma

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3595-3599

  Shi, Yuanping ^a   Zheng, Lu ^a   Luo, Guanghua ^a   Wei, Jiang ^a   Zhang, Jun ^a   Yu, Yang ^a   Feng, Yuehua ^a   Li, Min ^a   Xu, Ning ^b  

^a SOOCHOW UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Annexin V FITC PI assay; Apoptosis; Hepatocellular carcinoma; Human zinc finger 23; Real time RT PCR

Indexed keywords

CISPLATIN; MESSENGER RNA; UNCLASSIFIED DRUG; ZINC FINGER 23; ZINC FINGER PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CISPLATIN; FEMALE; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 80054756069     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Huang C, Jia Y, Yang S, Chen B, Sun H, Shen F and Wang Y: Characterization of ZNF23, a KRAB-containing protein that is down-regulated in human cancers and inhibits cell cycle progression. Exp Cell Res 313: 254-263, 2007. (Pubitemid 46048814)
2. Albertson DG, Collins C, McCormick F and Gray JW: Chromosome aberrations in solid tumors. Nat Genet 34: 369-376, 2003. (Pubitemid 36935328)
3. Castro MA, Onsten TG, Moreira JC and de Almeida RM: Chromosome aberrations in solid tumors have a stochastic nature. Mutat Res 600: 150-164, 2006.
4. Hansen LL, Jensen LL, Dimitrakakis C, Michalas S, Gilbert F, Barber HR, Overgaard J and Arzimanogiou II: Allelic imbalance in selected chromosomal regions in ovarian cancer. Cancer Genet Cytogenet 139: 1-8, 2002. (Pubitemid 36120398)
5. Qin LX and Tang ZY: The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 8: 193-199, 2002.
6. Shin E, Ryu HS, Kim SH, Jung H, Jang JJ and Lee K: The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18: 544-550, 2011.
7. Huang GW, Yang LY and Lu WQ: Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J Gastroenterol 11: 1705-1708, 2005.
8. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR and Berry DP: Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43: 979-992, 2007. (Pubitemid 46483030)
9. Guo C, Liu QG, Zhang L, Song T and Yang X: Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 8: 389-396, 2009.
10. Bellefroid EJ, Poncelet DA, Ucocq PJ, Revelant O and Martial JA: The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc Natl Acad Sci USA 88: 3608-3612, 1991. (Pubitemid 21916672)
11. Urrutia R: KRAB-containing zinc-finger repressor proteins. Genome Biol 4(231): 1-8, 2003.
12. Alas S, Ng CP and Bonavida B: Rituximab modifies the cisplatin- mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma. Clin Cancer Res 8: 836-845, 2002. (Pubitemid 34742116)
13. Qin LF and Ng IO: Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett 175: 27-38, 2002. (Pubitemid 33153041)
14. Huang C, Yang S, Ge R, Sun H, Shen F and Wang Y: ZNF23 induces apoptosis in human ovarian cancer cells. Cancer Lett 266: 135-143, 2008.
15. Eichenmuller M, von Schweinitz D and Kappler R: Betulinic acid treatment promotes apoptosis in hepatoblastoma cells. Int J Oncol 35: 873-879, 2009.
16. Mu R, Lu N, Wang J, Yin Y, Ding Y, Zhang X, Gui H, Sun Q, Duan H, Zhang L, Zhang Y, Ke X and Guo Q: An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro. Eur J Cancer Prev 19: 61-67, 2010.
17. Peroukides S, Bravou V, Alexopoulos A, Varakis J, Kalofonos H and Papadaki H: Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin. Histol Histopathol 25: 299-307, 2010.